Poland· PL-100040410

Madopar 62,5 mg

A levodopa und decarboxylasehemmer product containing levodopum + benserazidum, registered in Poland by Roche Polska Sp. z o.o.. The same ATC class is registered in 12 of our 19 countries.

ATC N04BA02

Checked against URPL (Poland) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about levodopum + benserazidumAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Levodopa und decarboxylasehemmer is registered in 12 of 19 countries.

Countries holding a registration under ATC N04BA02 (levodopa und decarboxylasehemmer), each read from that country’s own register.

This record: Poland, from URPL (Poland)
8 of them publish a price we can compare per daily dose

Search levodopa und decarboxylasehemmer products by name

Levodopa und decarboxylasehemmer · ATC N04BA02

12 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Switzerlandprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)

Active substance: Levodopum + Benserazidum
Manufacturer: Roche Polska Sp. z o.o.
Country: Poland (PL)
ATC code: N04BA02
ATC class: Levodopa und Decarboxylasehemmer
Reimbursed: Not published by this register
Source register: URPL (Poland)
Last checked: September 27, 2026

Packs & prices · 1

1 priced

gtin
05909990094912
100 szt.
PLN 26.48

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

158 interactions on record for levodopa und decarboxylasehemmer.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check levodopa und decarboxylasehemmer against other medicines How interaction checks work

Levodopa und decarboxylasehemmer · interactions on record

158 records

4 severe
122 moderate
14 minor

Most severe, free to view

ProcarbazineL01XB01severe
OzanimodL04AA38severe
OzanimodL04AE02severe
Methylthioninium chlorideV03AB17severe

18 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Levodopa und decarboxylasehemmer in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All levodopa und decarboxylasehemmer products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

Austria · Madopar, Madopar Cr
Belgium · Prolopa, Prolopa Hbs
Bulgaria · Maдопар, Мадопар Hbs
Czechia · Madopar
Germany · Levobens, Levodopa Benserazid Beta
Denmark · Levodopa-Benserazid Teva, Levodopa/Benserazid Orifarm
Estonia · Madopar, Madopar Hbs
Spain · Madopar, Madopar Retard
Finland · Levodopa/Benserazide Orifarm, Madopar
France · Levodopa Benserazide Teva, Lévodopa/Bensérazide Teva
United Kingdom (Northern Ireland) · Levodopa/Benserazide Teva Uk, Madopar
Greece · Madopar
Croatia · Madopar
Hungary · Madopar
Ireland · Madopar
Iceland · Madopar, Madopar Depot
Italy · Madopar
Lithuania · Madopar, Madopar Hbs
Luxembourg · Levodopa/Benserazid Devatis, Prolopa 125
Latvia · Madopar, Madopar Hbs
Netherlands · Levodopa/Benserazide Adoh, Levodopa/Benserazide Pch
Norway · Madopar, Madopar Depot
Portugal · Madopar, Madopar Hbs
Romania · Madopar, Madopar Depot
Sweden · Levodopa/Benserazid Ratiopharm, Levodopa/Benserazide Orifarm
Slovenia · Madopar

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/754b1a4a-99e3-468b-bfbc-212f012e40b4
GET /v1/drugs/754b1a4a-99e3-468b-bfbc-212f012e40b4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsułki",
  "source": "urpl",
  "strength": "50 mg + 12,5 mg",
  "packaging": "Rp ¦ Skasowane ¦ 6204\n30 kaps.\n05909990094912 ¦ Rp ¦ 43488\n100 kaps.",
  "substance": "Levodopum 50 mg + Benserazidi hydrochloridum 12.5 mg",
  "common_name": "Levodopum + Benserazidum",
  "pl_product_id": "100040410",
  "pozwolenie_nr": "00949",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

API reference MCP server Plans

See everything about levodopa und decarboxylasehemmer.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console